We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Promotion of “Low T” and the Role of Testosterone Clinical Trials—Reply

Lisa M. Schwartz, MD, MS1; Steven Woloshin, MD, MS1
[+] Author Affiliations
1The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
JAMA Intern Med. 2014;174(2):306-307. doi:10.1001/jamainternmed.2013.12733.
Text Size: A A A
Published online


In Reply We share the anxiety expressed by Schooling et al about conducting a large-scale randomized trial of testosterone therapy for frail, older men with hypogonadism, given the existing evidence of important harm. The best evidence of harm is from the Testosterone in Older Men With Mobility Limitations (TOM) trial,1 which randomized community-dwelling men 65 years and older with limitations in mobility and total serum testosterone levels lower than 350 ng/dL (to convert to nanomoles per liter, multiply by 0.0347) to placebo or testosterone gel (Testim 1%; Auxilium Pharmaceuticals Inc) for 6 months. The data safety monitoring board stopped the TOM trial early because of harm—more atherosclerotic events (myocardial infarction, sudden death, angioplasty, coronary artery bypass, or stroke) and more cardiovascular events (atherosclerotic events plus syncope, arrhythmias, peripheral edema, elevated blood pressure, and electrocardiographic changes).


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview





February 1, 2014
C. Mary Schooling, PhD; Gabriel M. Leung, MD; Lin Xu, PhD
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China2City University of New York (CUNY) School of Public Health, New York, New York
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
JAMA Intern Med. 2014;174(2):305-306. doi:10.1001/jamainternmed.2013.12750.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...